How Technology Is Transforming Health Care
In the mid-20th century Joseph Schumpeter, the noted
Austrian economist, popularized the term "creative destruction" to
denote transformation that accompanies radical innovation. In recent
years, our world has been "Schumpetered."
By virtue of the intensive infiltration of digital
devices into our daily lives, we have radically altered how we
communicate with one another and with our entire social network at once.
Everywhere we go, we take pictures and videos with our cellphone, the
one precious object that never leaves our side. Forget about going to a
video store to rent a movie and finding out it is not in stock. Just
download it at home and watch it on television, a computer monitor, a
tablet or even your phone. The Web lets us sample nearly all books in
print without even making a purchase and efficiently download the whole
book in a flash. Our lives have been radically transformed through
digital innovation. Radically transformed. Creatively destroyed.
But the most precious part of our existence – our health –
has thus far been largely unaffected, insulated and almost
compartmentalized from this digital revolution. How could this be?
Medicine is remarkably conservative to the point of being properly
characterized as sclerotic, even ossified. Beyond the reluctance and
resistance of physicians to change, the life science industry (companies
that develop and commercialize drugs, devices or diagnostic tests) and
government regulatory agencies are in a near-paralyzed state, unable to
break out of a broken model determining how their products are developed
or commercially approved. But that is about to change. Medicine is
about to go through its biggest shakeup in history.
For the first time we can digitize humans. We can
remotely and continuously monitor each heart beat, moment-to-moment
blood pressure readings, the rate and depth of breathing, body
temperature, oxygen concentration in the blood, glucose, brain waves,
activity, mood – all the things that make us tick. We can image any part
of the body and do a three-dimensional reconstruction, eventually
leading to the capability of printing an organ. Or, we can use a
miniature, handheld, high-resolution imaging device that rapidly
captures critical information anywhere, such as the scene of a motor
vehicle accident or a person's home in response to a call of distress.
We can determine all 6 billion letters ("life codes") of a person's
genome sequence.
And all of this information about an individual can be
assembled from wireless biosensors, genome sequencing or imaging to be
readily available, integrated with all the traditional medical data and
constantly updated. We now have the technology to digitize a human being
in highest definition, in granular detail, and in ways that most people
thought would not be possible.
This reflects an unprecedented super-convergence. It
would not be possible were it not for the maturation of the digital
world technologies – the ubiquity of smartphones, bandwidth, pervasive
connectivity and social networking. Beyond this, the perfect digital
storm includes immense, seemingly unlimited, computing power via cloud
server farms, remarkable biosensors, genome sequencing, imaging
capabilities and formidable health information systems.
Think of the cellphone, which is not only a hub of
telecommunications convergence, but also a remarkable number of devices
all rolled into one gadget: camera, video recorder, GPS, calculator,
watch, alarm clock, music player, voice recorder, photo album and
library of books – like a pluripotent stem cell. Armed with apps, it
carries out diverse functions from flashlight to magnifying glass. Then
connect it to a wireless network, and this tiny device is a web surfer,
word processor, video player, translator, dictionary, encyclopedia and
gateway to the world's knowledge base. And, by the way, it even texts,
emails and provides phone service. But now picture this device loaded
for medicine, capable of displaying all of one's vital signs in real
time, conducting laboratory analyses, sequencing parts of one's genome,
or even acquiring ultrasound images of one's heart, abdomen or unborn
baby.
These are the collective tools that lay the groundwork
for digitizing humans. This is a new era of medicine, in which each
person can be near fully defined at the individual level, instead of how
we practice medicine at a population level, with mass screening
policies for such conditions as breast or prostate cancer and use of the
same medication and dosage for a diagnosis rather than for a patient.
We are each unique human beings, but up until now there was no way to
establish one's biologic or physiologic individuality. There was no way
to determine a relevant metric like blood pressure around the clock
while a person is sleeping, or at work, or in the midst of an emotional
upheaval. This represents the next frontier of the digital revolution,
finally getting to the most important but heretofore insulated domain –
preserving our health.
We have early indicators that this train has left the
station. The first individual, a five-year-old boy who had his life
saved by genome sequencing, was recently documented. But it's not just
about finding the root molecular cause of why an individual is sick . We
can now perform whole genome sequencing of a fetus to determine what
conditions should be watched for postnatally. At the other end of the
continuum of life, we can do DNA sequencing to supplant a traditional
physical autopsy, to determine the cause of death. We can dissect,
decode and define individual granularity at the molecular level, from
womb to tomb.
That's just the start of illuminating the human black
box. Recognizing that we are walking event recorders and that we just
need biosensors to capture the data, and algorithms to process it, sets
up the ability to track virtually any metric. Today, these sensors are
wearable, like Band-Aids or wristwatches. But soon enough they will also
be embedded into our circulation in the form of nanosensors, the size
of a grain of sand, providing continuous surveillance of our blood for
the earliest possible detection of cancer, an impending heart attack or
the likelihood of a forthcoming autoimmune attack.
Yes, this does ring in the sci-fi concept of cyborgs, the
fusion of artificial and biological parts in humans. We've already been
there with cochlear implants for hearing loss, a trachea transplant,
and we're going there in the creation of embedded sensors that talk to
our cellphones via wireless body area networks in the future. With it
comes the familiar "check engine" capability that we are accustomed to
in our cars but never had before for our bodies. Think true, real
prevention for the first time in medical history.
We live in an extraordinary data-rich universe, a world that had only accumulated 1 billion gigabytes (109
or 1,000,000,000 bytes of data) from the dawn of civilization until
2003. But now, we are generating multiple zettabytes – each representing
1 trillion gigabytes – each year and will exceed 35 zettabytes by 2020,
roughly equivalent to the amount of data on 250 billion DVDs. Sensors
are now the dominant source of worldwide-generated data, with 1,250
billion gigabytes in 2010, representing more bits than all of the stars
in the universe.
The term "massively parallel" is an important one that,
in part, accounts for this explosion of data and brings together the
computer, digital and life science domains. Note the convergence: from
single chips that contain massively parallel processor arrays, to
supercomputers with hundreds of thousands of central processing units,
to whole-genome sequencing that is performed by breaking the genomes
into tiny pieces and determining the life codes in a massively parallel
fashion. In 2011, the Watson IBM computer system beat champion humans on
the game show, "Jeopardy!" Watson is equipped with a 15-terabyte (1012) or 15,000,000,000,000-byte databank and massively parallel 2,880-processor cores.
So, beyond its television premiere and victory, where was Watson first deployed? At Columbia University and the University of Maryland medical centers to provide a cybernetic assistant service to doctors.
David Gelernter's February 2011 op-ed in The Wall Street Journal,
"Coming Next: A Supercomputer Saves Your Life," introduced the concept
of a WikiWatson supercomputer that could bring together the whole
world's medical literature and clinical expertise. Putting a massive
databank to use to improve health care is emblematic of the overlay of
the digital and medical worlds.
In some health care systems, patients can now directly
download their laboratory reports and medical records, which they were
never allowed to do in the past. Any consumer with adequate funds can
have his or her genome scanned or even wholly sequenced.
But just having these technological capabilities will not
catapult medicine forward. The gridlock of the medical community,
government and the life science industry will not facilitate change or a
willingness to embrace and adopt innovation. The U.S. government has
been preoccupied with health care "reform," but this refers to improving
access and insurance coverage and has little or nothing to do with
innovation. Medicine is currently set up to be maximally imprecise.
Private practice physicians render "by the yard" and are rewarded for
doing more procedures. Medical care is largely shaped by guidelines,
indexed to a population rather than an individual. And the evidence from
clinical research is derived from populations that do not translate to
the real world of persons. The life science industry has no motivation
to design drugs or devices that are only effective, however strikingly,
for a small, well-defined population segment. At the same time, the
regulatory agencies are entirely risk-averse and, as a result, are
suppressing remarkably innovative, and even frugal, opportunities to
change medicine. The end result is that most of our screening tests and
treatments are overused and applied to the wrong individuals, promoting
vast waste. And virtually nothing is being done to accelerate true
prevention of disease.
In fact, consumers must provide the impetus for new
medicine – a new medicine that is no longer paternalistic, since the
doctor does not necessarily know best anymore. The American Medical
Association has lobbied the government hard for consumers not to have
direct access to their genomic data, asserting that this must be
mediated through physicians.
We know that 90 percent of physicians are uncomfortable
and largely unwilling to make decisions based on their patients' genomic
information. But it is your DNA, your cellphone and your right to have
all of your medical data and information. With a medical profession
particularly incapable of making a transition to practicing
individualized medicine, despite a new array of powerful tools, isn't it
time for consumers to drive this capability?
A revolution in technology that is based on the primacy
of individuals mandates a revolution by consumers in order for new
medicine to take hold. We desperately need medicine to be Schumpetered,
to be radically transformed. We need the digital world to invade the
medical cocoon and to exploit the newfound and exciting technological
capabilities of digitizing human beings.
No comments